1 |
Wyeth LLC et al v. Alembic Pharmaceuticals, Ltd. et al |
1:16-cv-01305 |
D.Del. |
|
|
|
|
2 |
Wyeth LLC et al v. Alembic Pharmaceuticals, Ltd. et al |
1:16-cv-01305 |
D.Del. |
|
|
|
|
3 |
Wyeth LLC et al v. Alembic Pharmaceuticals, Ltd. et al |
1:16-cv-01305 |
D.Del. |
|
|
|
|
4 |
Wyeth LLC et al v. Alembic Pharmaceuticals, Ltd. et al |
1:16-cv-01305 |
D.Del. |
|
|
|
|
5 |
Wyeth LLC et al v. Alembic Pharmaceuticals, Ltd. et al |
1:16-cv-01305 |
D.Del. |
|
|
|
|
6 |
Teijin Limited et al v. Ranbaxy Pharmaceuticals Inc. et al |
1:14-cv-00117 |
D.Del. |
|
|
|
|
7 |
Teijin Limited et al v. Ranbaxy Pharmaceuticals Inc. et al |
1:14-cv-00117 |
D.Del. |
|
|
|
|
8 |
Teijin Limited et al v. Ranbaxy Pharmaceuticals Inc. et al |
1:14-cv-00117 |
D.Del. |
|
|
|
|
9 |
Sepracor Inc. et al v. Sun Pharmaceutical Industries, Ltd. |
5:08-cv-00247 |
E.D.N.C. |
|
|
|
|
10 |
Sepracor Inc. et al v. Sun Pharmaceutical Industries, Ltd. |
5:08-cv-00247 |
E.D.N.C. |
|
|
|
|
11 |
Sepracor Inc. et al v. Sun Pharmaceutical Industries, Ltd. |
5:08-cv-00247 |
E.D.N.C. |
|
|
|
|
12 |
SEPRACOR INC. et al v. SUN PHARMACEUTICAL INDUSTRIES LTD. |
3:07-cv-04213 |
D.N.J. |
|
- 6 University/Government/Non-profit
- 8 Product company
|
|
|
13 |
SEPRACOR INC. et al v. SUN PHARMACEUTICAL INDUSTRIES LTD. |
3:07-cv-04213 |
D.N.J. |
|
- 6 University/Government/Non-profit
- 8 Product company
|
|
|
14 |
Sanofi et al v. Watson Laboratories Inc. et al |
1:14-cv-00264 |
D.Del. |
|
|
|
|
15 |
Sanofi et al v. Watson Laboratories Inc. et al |
1:14-cv-00264 |
D.Del. |
|
|
|
|
16 |
Sanofi et al v. Sun Pharma Global FZE et al |
1:15-cv-01208 |
D.Del. |
|
|
|
|
17 |
Sanofi et al v. Sun Pharma Global FZE et al |
1:15-cv-01208 |
D.Del. |
|
|
|
|
18 |
Sanofi et al v. Sun Pharma Global FZE et al |
1:14-cv-00294 |
D.Del. |
|
|
|
|
19 |
Sanofi et al v. Sun Pharma Global FZE et al |
1:14-cv-00294 |
D.Del. |
|
|
|
|
20 |
Purdue Pharma Products LP et al v. Sun Pharmaceutical Industries Ltd. et al |
1:09-cv-00833 |
D.Del. |
|
|
|
|
21 |
Purdue Pharma Products LP et al v. Sun Pharmaceutical Industries Ltd. et al |
1:09-cv-00833 |
D.Del. |
|
|
|
|
22 |
Pharmacyclics LLC et al v. Sun Pharma Global FZE et al |
1:18-cv-01543 |
D.Del. |
|
|
|
|
23 |
Pharmacyclics LLC et al v. Sun Pharma Global FZE et al |
1:18-cv-01543 |
D.Del. |
|
|
|
|
24 |
Pharmacyclics LLC et al v. Shilpa Medicare Limited et al |
1:18-cv-00237 |
D.Del. |
|
|
|
|
25 |
Pharmacyclics LLC et al v. Shilpa Medicare Limited et al |
1:18-cv-00237 |
D.Del. |
|
|
|
|
26 |
Pfizer Inc. et al v. Sun Pharmaceutical Industries Limited et al |
1:17-cv-01597 |
D.Del. |
|
|
|
|
27 |
Pfizer Inc. et al v. Sun Pharmaceutical Industries Limited et al |
1:17-cv-01597 |
D.Del. |
|
|
|
|
28 |
Pfizer Inc. et al v. Sun Pharmaceutical Industries Limited et al |
1:17-cv-01597 |
D.Del. |
|
|
|
|
29 |
Pfizer Inc. et al v. Sun Pharmaceutical Industries Limited et al |
1:17-cv-01597 |
D.Del. |
|
|
|
|
30 |
Pfizer Inc. et al v. Sun Pharmaceutical Industries Limited et al |
1:17-cv-01597 |
D.Del. |
|
|
|
|
31 |
Pfizer Inc. et al v. C.P. Sun Pharmaceutical Industries Limited et al |
1:17-cv-00159 |
D.Del. |
|
|
|
|
32 |
Pfizer Inc. et al v. C.P. Sun Pharmaceutical Industries Limited et al |
1:17-cv-00159 |
D.Del. |
|
|
|
|
33 |
Pfizer Inc. et al v. C.P. Sun Pharmaceutical Industries Limited et al |
1:17-cv-00159 |
D.Del. |
|
|
|
|
34 |
Novartis Phar Corp, et al v. Sun Pharm Ind Ltd |
1:04-cv-05477 |
N.D.Ill. |
|
|
|
|
35 |
Novartis Phar Corp, et al v. Sun Pharm Ind Ltd |
1:04-cv-05477 |
N.D.Ill. |
|
|
|
|
36 |
Novartis Phar Corp, et al v. Sun Pharm Ind Ltd |
1:04-cv-05477 |
N.D.Ill. |
|
|
|
|
37 |
Novartis Phar Corp, et al v. Sun Pharm Ind Ltd |
1:04-cv-05477 |
N.D.Ill. |
|
|
|
|
38 |
Meda Pharmaceuticals Inc. v. Sun Pharmaceutical Industries Ltd. |
1:09-cv-00241 |
D.Del. |
|
|
|
|
39 |
In Re: Rivastigmine Patent Litigation |
1:05-md-01661 |
S.D.N.Y. |
|
- 8 Product company
- 13 Corporate-inventor-started company
|
|
|
40 |
In Re: Rivastigmine Patent Litigation |
1:05-md-01661 |
S.D.N.Y. |
|
- 8 Product company
- 13 Corporate-inventor-started company
|
|
|
41 |
In Re: Rivastigmine Patent Litigation |
1:05-md-01661 |
S.D.N.Y. |
|
- 8 Product company
- 13 Corporate-inventor-started company
|
|
|
42 |
In Re: Rivastigmine Patent Litigation |
1:05-md-01661 |
S.D.N.Y. |
|
- 8 Product company
- 13 Corporate-inventor-started company
|
|
|
43 |
In Re: Rivastigmine Patent Litigation |
1:05-md-01661 |
S.D.N.Y. |
|
- 8 Product company
- 13 Corporate-inventor-started company
|
|
|
44 |
Eli Lilly and Company v. Sun Pharmaceutical Industries, Limited |
2:07-cv-13989 |
E.D.Mich. |
|
|
|
|
45 |
Cephalon, Inc. v. Sun Pharmaceutical Industries, Inc. et al |
2:11-cv-14181 |
E.D.Mich. |
|
|
|
|
46 |
CEPHALON, INC. v. SUN PHARMACEUTICAL INDUSTRIES, INC. et al |
3:11-cv-05474 |
D.N.J. |
|
|
|
|
47 |
Cephalon Inc. v. Sun Pharma Global FZE et al |
1:13-cv-02096 |
D.Del. |
|
|
|
|
48 |
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. et al v. SUN PHARMACEUTICAL INDUSTRIES LTD. et al |
3:17-cv-08819 |
D.N.J. |
|
|
|
|
49 |
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. et al v. SUN PHARMACEUTICAL INDUSTRIES LTD. et al |
3:17-cv-08819 |
D.N.J. |
|
|
|
|
50 |
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mankind Pharma Ltd. et al |
1:18-cv-01689 |
D.Del. |
|
|
|
|